Raymond James Upgrades Welltower Inc. to 'Buy'

Raymond James has raised its rating on Welltower Inc. to 'buy' with a $226 price target.

Key Points

  • Raymond James analyst David Rodgers upgraded Welltower Inc. (NYSE: WELL) to 'buy' with a target price of $226 on June 17, 2026.
  • Welltower shares traded at $213.5 with a market cap of $150.7 billion and a forward P/E ratio of 63.5.
  • Insider transactions included CEO Shankh Mitra selling shares, while several analysts maintained 'buy' ratings with targets up to $255.

Important disclosure: EarningsIQ is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Raymond James has upgraded its rating on Welltower Inc. (NYSE: WELL) to 'buy' with a new price target of $226. This change, announced on June 17, 2026, reflects analyst David Rodgers' positive outlook on the company's prospects.

What Changed in Raymond James's Welltower Position

Raymond James's latest move to upgrade Welltower Inc. to a 'buy' rating comes with a price target of $226. This reflects confidence in Welltower's strategy and market position, aligning with the company's current trading price of about $213.5.

Other Institutional Activity in Welltower

Several major funds have adjusted their positions in Welltower. BlackRock, Inc. increased its holdings by 1,223,102 shares, ending with about 74 million shares valued at $14.6 billion. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both held steady with over 45 million and 41 million shares, respectively. Meanwhile, State Street Corp slightly reduced its stake by 199,551 shares, maintaining over 41 million shares worth approximately $8.2 billion. Cohen & Steers, Inc. significantly boosted its investment by 2,331,605 shares, reaching over 35 million shares valued at $7.1 billion.

Welltower Inc. Stock Holds Steady

Shares of Welltower Inc. (NYSE: WELL) traded near $213.5. The company boasts a market cap of $150.7 billion, a P/E ratio of 103.1, and a forward P/E of 63.5. Its beta is 0.78, suggesting lower volatility compared to the market. The stock's 52-week range spans from $148.97 to $221.68, with a 50-day moving average of $210.72 and a 200-day moving average of $194.36.

Recent Earnings

Welltower reported revenue of approximately $11.8 billion with a growth rate of 38.3%. Its net margin stands at 11.96%, and it achieved a return on equity of 3.67%. The next earnings report is expected on July 27, 2026.

Dividend

Welltower offers an annual dividend rate of $2.96, yielding 1.39%. The dividend payout ratio is 139.61%, indicating the company returns a significant portion of its earnings to shareholders.

Insider Buying and Selling at Welltower Inc.

Recent insider activity at Welltower includes CEO Shankh Mitra selling 162 shares on May 27, 2026. Meanwhile, Dennis Lopez purchased 63 shares at $216.01 on May 21, 2026. Kenneth Bacon also had transactions on May 1, 2026, buying and selling 2,627 shares.

Analysts Set New Price Targets

On June 17, 2026, Raymond James reinstated its 'buy' rating for Welltower with a $226 price target. Other analysts, including Wells Fargo and Scotiabank, have maintained 'buy' ratings with price targets of $237 and $248, respectively. Overall, the consensus is a 'buy' with a mean target price of $236.75 from 20 analyst opinions.

About Welltower Inc.

Welltower Inc. operates in the real estate sector, focusing on healthcare facilities. Based in Toledo, Ohio, and led by CEO Shankh S. Mitra, the company provides rental housing for seniors in the U.S., U.K., and Canada. Its portfolio includes over 2,000 senior living communities, aiming to create vibrant environments for older adults.

Bottom Line

Raymond James's upgrade of Welltower to 'buy' underscores confidence in its growth potential. With a strong market position and a robust portfolio, Welltower remains a key player in the healthcare real estate sector. Investors track these upgrades and insider activities to gauge market sentiment and potential future performance.

Get Welltower Inc. alerts

New 13F filings, insider trades, and analyst moves on $WELL, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.